Search Results - "Martí Massó, José F."

Refine Results
  1. 1
  2. 2

    α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers by Gorostidi, Ana, Bergareche, Alberto, Ruiz-Martínez, Javier, Martí-Massó, José F., Cruz, María, Varghese, Shiji, Qureshi, Mohamed M., Alzahmi, Fatimah, Al-Hayani, Abdulmonem, de Munáin, Adolfo López, El-Agnaf, Omar M.A.

    Published in PloS one (27-12-2012)
    “…The diagnosis of Parkinson’s disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations by Ruiz-Martínez, Javier, Gorostidi, Ana, Goyenechea, Estibaliz, Alzualde, Ainhoa, Poza, Juan José, Rodríguez, Francisco, Bergareche, Alberto, Moreno, Fermín, López de Munain, Adolfo, Martí Massó, José F.

    Published in Movement disorders (01-09-2011)
    “…It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor…”
    Get full text
    Journal Article
  6. 6

    Response to treatment with corticoids in a case of inflammatory amyloid angiopathy without performing a biopsy by de la Riva, Patricia, Moreno, Fermín, Carrera, Nieves, Barandiarán, Myriam, Arruti, Maialen, Martí-Massó, José F

    Published in Revista de neurologiá (01-10-2012)
    “…Inflammatory amyloid angiopathy (IAA) is an infrequent presenting symptom of the recently recognised cerebral amyloid angiopathy and its definitive diagnosis…”
    Get full text
    Journal Article
  7. 7

    Cinnarizine-induced parkinsonism: Ten years later by Martí-Massó, José F., Poza, Juan J.

    Published in Movement disorders (01-05-1998)
    “…A retrospective study was carried out to investigate the evolution of patients diagnosed with cinnarizineinduced parkinsonism (CIP) over the past 15 years. A…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease by Ruiz-Martínez, Javier, Azcona, Luis J, Bergareche, Alberto, Martí-Massó, Jose F, Paisán-Ruiz, Coro

    Published in Neurology. Genetics (01-10-2017)
    “…Despite the enormous advancements made in deciphering the genetic architecture of Parkinson disease (PD), the majority of PD is idiopathic, with single gene…”
    Get full text
    Journal Article
  10. 10

    Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers by Gorostidi, Ana, Bergareche, Alberto, Ruiz-Martínez, Javier, Martí-Massó, José F, Cruz, María, Varghese, Shiji, Qureshi, Mohamed M, Alzahmi, Fatimah, Al-Hayani, Abdulmonem, López de Munáin, Adolfo, El-Agnaf, Omar M A

    Published in PloS one (2012)
    “…The diagnosis of Parkinson's disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain) by Ruiz-Martínez, Javier, Gorostidi, Ana, Ibañez, Berta, Alzualde, Ainhoa, Otaegui, David, Moreno, Fermin, de Munain, Adolfo López, Bergareche, Alberto, Gómez-Esteban, Juan Carlos, Massó, José F. Martí

    Published in Movement disorders (30-10-2010)
    “…The LRRK2 R1441G mutation was first identified in Basque families and it is responsible for 46% of familial Parkinson's disease (PD) and for 2.5% of sporadic…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers by Gorostidi, Ana, Bergareche, Alberto, Ruiz-Martínez, Javier, Martí-Massó, José F, Cruz, María, Varghese, Shiji, Qureshi, Mohamed M, Alzahmi, Fatimah, Al-Hayani, Abdulmonem, de Munáin, Adolfo López, El-Agnaf, Omar M.A

    Published in PloS one (27-12-2012)
    “…The diagnosis of Parkinson's disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of…”
    Get full text
    Journal Article
  16. 16

    Familial Parkinson's disease: Clinical and genetic analysis of four Basque families by Paisàn-Ruìz, Coro, Sàenz, Amets, de Munain, Adolfo Lòpez, Martì, Itxaso, Martìnez Gil, Angel, Martì-Massò, Josè F., Pèrez-Tur, Jordi

    Published in Annals of neurology (01-03-2005)
    “…During the last few years several loci have been linked to Mendelian forms of Parkinson's disease (PD). To date, 5 causative genes of 10 identified loci are…”
    Get full text
    Journal Article
  17. 17

    Olfactory deficits and cardiac 123 I‐MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations by Ruiz‐Martínez, Javier, Gorostidi, Ana, Goyenechea, Estibaliz, Alzualde, Ainhoa, Poza, Juan José, Rodríguez, Francisco, Bergareche, Alberto, Moreno, Fermín, López de Munain, Adolfo, Martí Massó, José F.

    Published in Movement disorders (01-09-2011)
    “…It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor…”
    Get full text
    Journal Article
  18. 18

    High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome by Urtasun, M, López de Munain, A, Carrera, N, Martí-Massó, J F, López de Dicastillo, G, Mozo, C

    Published in The Annals of pharmacotherapy (01-01-1992)
    “…To evaluate the efficacy of high-dose intravenous gammaglobulin (IGIV) versus plasmapheresis in patients with severe Guillain-Barré syndrome (GBS) and compare…”
    Get more information
    Journal Article
  19. 19
  20. 20